Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 5 | 20 | 8 | 1 | 3 | 33 |
Thyroid neoplasms | D013964 | EFO_0003841 | — | — | 3 | 2 | 1 | 1 | 5 |
Thyroid diseases | D013959 | — | E00-E07 | — | 2 | 2 | 1 | 1 | 4 |
Papillary thyroid cancer | D000077273 | — | — | — | 1 | 1 | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lung neoplasms | D008175 | — | C34.90 | 7 | 27 | 10 | — | 1 | 38 |
Carcinoma | D002277 | — | C80.0 | 2 | 12 | 4 | — | — | 16 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 2 | 5 | 2 | — | — | 8 |
Small cell lung carcinoma | D055752 | — | — | — | 4 | 3 | — | — | 7 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 4 | 1 | — | — | 6 |
Colorectal neoplasms | D015179 | — | — | 1 | 3 | 2 | — | — | 5 |
Adenocarcinoma | D000230 | — | — | 1 | 3 | 1 | — | — | 4 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | — | 3 | 1 | — | — | 4 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | 4 | 1 | — | — | 4 |
Sarcoma | D012509 | — | — | — | 3 | 2 | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 6 | 8 | — | — | — | 13 |
Recurrence | D012008 | — | — | 1 | 6 | — | — | — | 6 |
Gastrointestinal neoplasms | D005770 | — | C26.9 | — | 5 | — | — | — | 5 |
Digestive system neoplasms | D004067 | — | — | — | 5 | — | — | — | 5 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | 3 | — | — | — | 3 |
Squamous cell carcinoma | D002294 | — | — | — | 3 | — | — | — | 3 |
Esophageal squamous cell carcinoma | D000077277 | — | — | — | 3 | — | — | — | 3 |
Esophageal neoplasms | D004938 | — | C15 | — | 3 | — | — | — | 3 |
Gastrointestinal diseases | D005767 | — | — | — | 3 | — | — | — | 3 |
Digestive system diseases | D004066 | EFO_0000405 | K92.9 | — | 3 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | — | — | — | — | 1 |
Drug common name | Catequentinib |
INN | catequentinib |
Description | Anlotinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target vascular endothelial growth factor receptor 2, vascular endothelial growth factor receptor 3, fibroblast growth factor receptor 1, and vascular endothelial growth factor receptor 1. |
Classification | Small molecule |
Drug class | tyrosine kinase inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1 |
PDB | — |
CAS-ID | 1058156-90-3 |
RxCUI | — |
ChEMBL ID | CHEMBL4303201 |
ChEBI ID | — |
PubChem CID | 25017411 |
DrugBank | DB11885 |
UNII ID | GKF8S4C432 (ChemIDplus, GSRS) |